SARS CoV 2 News and Research

RSS

Oral SARS-CoV-2 vaccine shows promise in monkeys

A new paper in Biology Methods and Protocols, published by Oxford University Press, indicates that researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.

13 Sep 2023

COVID-19 doubles risk of early type 1 diabetes signs in high-risk children

New research in JAMA finds a temporal association between SARS-CoV-2 infections and the onset of islet autoimmunity, a precursor to type 1 diabetes, in genetically predisposed infants. The study underscores COVID-19 as a potential risk factor for the development of this form of diabetes in young children.

13 Sep 2023

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

Researchers have isolated a new SARS-CoV-2 Omicron subvariant, BA.2.86, revealing its ability to escape neutralizing antibodies five-fold greater than its ancestor strain. Despite its enhanced immune evasion capabilities, BA.2.86 has not shown a significant difference in spread compared to other current variants.

13 Sep 2023

UC Riverside study uncovers COVID's Achilles heel

New UC Riverside research has revealed COVID's Achilles heel - its dependence on key human proteins for its replication - which can be used to prevent the virus from making people sick.

13 Sep 2023

Immunity following vaccination provides better protection against COVID-19

A team from the UNIGE and the HUG analyzed the contacts of 50,000 COVID-19 positive cases. Immunity following vaccination provides better protection for those around you.

12 Sep 2023

How COVID-19 targets the pancreas revealed

The study uncovers the role of the PLAC8 protein in making the human pancreas vulnerable to SARS-CoV-2 infection, leading to pancreatic injury and complications in severe COVID-19 cases. The findings open up new avenues for understanding how the virus affects multiple organ systems and offer a potential target for future treatments.

12 Sep 2023

Many 'mild' COVID patients still battling lung damage a year later

A recent PLoS ONE study reveals that severe COVID-19 patients are at higher risk of long-term pulmonary impairments, with nearly half experiencing reduced lung function a year after disease onset. The study underscores the need for ongoing monitoring to manage 'long COVID' symptoms effectively.

12 Sep 2023

SARS-CoV-2 infection can exacerbate production of auto-antibodies relating to auto-immune diseases

An article published in NPJ Aging, a Springer Nature journal, reveals that natural production of auto-antibodies increases with age and that infection by SARS-CoV-2 can exacerbate production of auto-antibodies relating to auto-immune diseases, helping to explain why aging increases the chances of developing severe COVID-19.

12 Sep 2023

Sepsis occurs more frequently than previously estimated, but mortality rates have declined

Sepsis, or blood poisoning, occurs more frequently than previously estimated by professionals. At the same, mortality rates have declined sharply. The two are connected.

12 Sep 2023

Is the coadministration of a COVID-19 vaccine with a seasonal influenza vaccine safe and efficacious?

Researchers investigated the comparative efficacy and safety of the simultaneous COVID-19 and seasonal influenza vaccination regimen compared to SARS-CoV-2 vaccination alone among healthcare workers who had received one or two COVID-19 booster doses.

12 Sep 2023

The safety and efficacy of the nano-based COVID-19 vaccine

A recent study evaluated the safety and efficacy of the GBP510 vaccine against SARS-CoV-2 infection.

12 Sep 2023

Vaccination amps up antibody response and cuts down COVID severity, UK study shows

UK study reveals COVID-19 vaccination effectively boosts anti-S antibody levels and reduces symptom severity post-infection, irrespective of the viral variant involved. High antibody levels are linked to quicker viral clearance, suggesting reduced transmission risk.

10 Sep 2023

Elite athletes bounce back strong: No long-term heart risks after COVID-19 recovery

The study finds that elite athletes who recovered from COVID-19 did not experience long-term negative effects on their cardiac health, allowing for the successful resumption of high-level sports. The findings also suggest that proper screening and medical counseling can pave the way for safe returns to sports post-COVID-19.

10 Sep 2023

SARS CoV 2 News and Research

Oral SARS-CoV-2 vaccine shows promise in monkeys

COVID-19 doubles risk of early type 1 diabetes signs in high-risk children

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

UC Riverside study uncovers COVID's Achilles heel

Immunity following vaccination provides better protection against COVID-19

How COVID-19 targets the pancreas revealed

Many 'mild' COVID patients still battling lung damage a year later

SARS-CoV-2 infection can exacerbate production of auto-antibodies relating to auto-immune diseases

Sepsis occurs more frequently than previously estimated, but mortality rates have declined

Is the coadministration of a COVID-19 vaccine with a seasonal influenza vaccine safe and efficacious?

The safety and efficacy of the nano-based COVID-19 vaccine

Vaccination amps up antibody response and cuts down COVID severity, UK study shows

Elite athletes bounce back strong: No long-term heart risks after COVID-19 recovery

Evaluating the efficacy of third dose booster vaccine against SARS-CoV-2 in patients with cancer

Study reports an increase in incidence of islet autoimmunity after SARS-CoV-2 infection in young children

Latest updates on SARS-CoV-2 variants identified in the UK

UTSA researchers study the mechanism of action of Sweet Annie's medicinal compounds

Senolytic therapy in mild Alzheimer’s disease shows safety in phase I trial

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Is there an association between the COVID-19 pandemic and cancer incidence?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News